112 related articles for article (PubMed ID: 1190249)
1. Evaluation of preparations of patent blue (Alphazurine 2G) dye for parenteral use.
Newton DW; Rogers AG; Becker CH; Torosian G
Am J Hosp Pharm; 1975 Sep; 32(9):912-7. PubMed ID: 1190249
[TBL] [Abstract][Full Text] [Related]
2. Allergic reaction to Patent Blue Violet during lymphography.
Hietala SO; Hirsch JI; Faunce HF
Lymphology; 1977 Sep; 10(3):158-60. PubMed ID: 592887
[TBL] [Abstract][Full Text] [Related]
3. Chemical structure and purity of dyes used in lymphograms.
Hiranaka PK; Kleinman LM; Sokoloski EA; Fales HM
Am J Hosp Pharm; 1975 Sep; 32(9):928-30. PubMed ID: 1190251
[TBL] [Abstract][Full Text] [Related]
4. Toxic effect of patent blue violet on rat lymph node lymphocytes.
Sokolowski J; Engeset A
Lymphology; 1974 Mar; 7(1):28-31. PubMed ID: 4855227
[No Abstract] [Full Text] [Related]
5. Properties and characteristics of the dyes injected to assist axillary sentinel node localization in breast surgery.
Masannat Y; Shenoy H; Speirs V; Hanby A; Horgan K
Eur J Surg Oncol; 2006 May; 32(4):381-4. PubMed ID: 16515852
[TBL] [Abstract][Full Text] [Related]
6. [Patent blue V dye for hemoglobin determination in bone marrow cells].
Schramm G; Senn A
Pharm Acta Helv; 1978; 53(2):53-5. PubMed ID: 674238
[No Abstract] [Full Text] [Related]
7. Final report on the safety assessment of Basic Blue 99.
Cosmetic Ingredient Review Expert Panel
Int J Toxicol; 2007; 26 Suppl 2():51-63. PubMed ID: 17613131
[TBL] [Abstract][Full Text] [Related]
8. [Nomenclature and Identification Method of Non-Permitted Dyes of Patent Blue Group].
Shinya M; Ki M; Yamaguchi Y
Shokuhin Eiseigaku Zasshi; 2020; 61(2):58-62. PubMed ID: 32336710
[TBL] [Abstract][Full Text] [Related]
9. Allergic reactions: following patent blue dye injection.
Sinclair DJ; Perera FA
Can Med Assoc J; 1969 Nov; 101(10):100-1. PubMed ID: 5348873
[No Abstract] [Full Text] [Related]
10. Why certain dyes are useful for localizing the sentinel lymph node.
Tsopelas C; Sutton R
J Nucl Med; 2002 Oct; 43(10):1377-82. PubMed ID: 12368377
[TBL] [Abstract][Full Text] [Related]
11. [Allergy to patent blue: lymphangiography without it (author's transl)].
Vadon G
Rontgenblatter; 1978 Jan; 31(1):49-51. PubMed ID: 74849
[No Abstract] [Full Text] [Related]
12. Extemporaneous preparation of methyldopa in two syrup vehicles.
Newton DW; Rogers AG; Becker CH; Torosian G
Am J Hosp Pharm; 1975 Aug; 32(8):817-21. PubMed ID: 238389
[TBL] [Abstract][Full Text] [Related]
13. Blue angioedema of eyelip after patent blue injection for lymphatic mapping procedure.
Weng PW; Hsu HM; Chen TW; Hsieh CB; Chang TM; Chen VT; Yu JC
Eur J Cancer Care (Engl); 2007 Jul; 16(4):390-1. PubMed ID: 17587366
[TBL] [Abstract][Full Text] [Related]
14. Anaphylaxis from alphazurine 2G during lymphography.
Kopp WL
JAMA; 1966 Nov; 198(6):668-9. PubMed ID: 5953446
[No Abstract] [Full Text] [Related]
15. [Disulfin blue solution i.v. as diagnostic in dermatology and surgery].
Frost E; Seidlein HJ
Pharm Prax; 1966; 7():152-5. PubMed ID: 6001087
[No Abstract] [Full Text] [Related]
16. Patent blue V encapsulation in liposomes: potential applicability to endolympatic therapy and preoperative chromolymphography.
Hirnle P; Harzmann R; Wright JK
Lymphology; 1988 Sep; 21(3):187-9. PubMed ID: 3199875
[TBL] [Abstract][Full Text] [Related]
17. [The value of disulphine blue injection in wound treatment].
Sander E
Zentralbl Chir; 1967; 92(26a Pt 1):1085-6. PubMed ID: 4874246
[No Abstract] [Full Text] [Related]
18. [Hazardous complications after injection of patent blue-violet as a complication lymphography].
Platzbecker H; Köhler K; Lucas D
Z Arztl Fortbild (Jena); 1970 Dec; 64(3):1224-5. PubMed ID: 5504416
[No Abstract] [Full Text] [Related]
19. Investigation of the role of electrolytes and non-electrolytes on the cloud point and dye solubilization in antidepressant drug imipramine hydrochloride solutions.
Alam MS; Kabir-Ud-Din
Colloids Surf B Biointerfaces; 2008 Aug; 65(1):74-9. PubMed ID: 18423990
[TBL] [Abstract][Full Text] [Related]
20. Stability and compatibility of lidocaine hydrochloride with selected large-volume parenterals and drug additives.
Kirschenbaum HL; Aronoff W; Perentesis GP; Plitz GW; Cutie AJ
Am J Hosp Pharm; 1982 Jun; 39(6):1013-5. PubMed ID: 7102682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
